Biostat® has begun 2022 with an agreement with the Maria Sklodowska-Curie National Research Institute of Oncology - National Research Institute in Gliwice. This is the beginning of a promising collaboration, with the purpose of conducting a clinical trial to develop an effective therapeutic solution in advanced, progressive adrenal cortex cancer.

The project received financial support from the Medical Research Agency in the field of rare diseases. For the Research and Development Center Biostat®, a cooperation with such a prestigious research unit in Poland - the National Institute of Oncology - is a great honor. Under the contract for 2022-2027, BioStat® will be responsible for comprehensive service and management of the trial.

We are pleased for our growing recognition in the world of science as a CRO organization and that we have the opportunity to support the implementation of such key and prospective projects in the field of oncology.

> Learn more about Biostat's clinical research services